Amino Collective

Rematiq is a technology company specializing in AI-driven platforms for automating product compliance in the medical technology industry. Its software streamlines regulatory processes and manages product lifecycles, offering features such as impact and gap analysis, requirements management, regulatory intelligence, and change management. This enables medical innovators to efficiently navigate regulatory complexities throughout the product lifecycle.

Nine self contained Environmental Sensors monitor conditions related to building spaces and equipment Cloud Based Analytics turns that sensor data Into real time alerts and other actionable intelligence. Open platform designed to integrate with other sensors and data sources, and combine their output at the analytical stage to create more refined intelligence.

ExpressionEdits is a biotechnology company focused on enhancing the redesign of synthetic DNA instructions to improve protein expression. Utilizing an AI-driven approach, the company aims to transform the standards of protein production, which is crucial for advancements in healthcare and biotechnology. ExpressionEdits operates a research platform specifically designed to enhance transgene expression in mammalian systems, thereby increasing recombinant protein yields and improving the quality and efficacy of DNA medicines. The team comprises scientists and engineers who are committed to developing innovative technologies that align with biological processes found in nature, ultimately supporting researchers in their efforts to understand genetic inheritance of transgenes.

Anima is a next-generation clinical operating system designed to enhance the efficiency of care teams in delivering optimal care plans to patients swiftly. The platform facilitates online consultations and offers a range of features, including comprehensive patient history management, one-click coding for record-keeping, and automated patient communications. It also incorporates limited assignment capabilities and patient access, along with integrated email and SMS messaging. Anima's advanced assignment and triage functionalities streamline workflows, while its full integration with electronic health records (EHR) ensures that notes are automatically generated, coded, and saved in the patient's record.

Biomia is a synthetic biology company dedicated to developing plant-derived natural products aimed at addressing unmet medical needs in pain, addiction, and depression. The company utilizes a drug discovery engine that integrates machine learning and biosynthesis to create therapeutics inspired by plant molecules. This innovative approach allows Biomia to conduct pre-clinical tests on both natural and novel small-molecule drug candidates. By focusing on these areas, Biomia seeks to provide effective solutions for patients suffering from various mental health challenges, promoting healing and improving quality of life.

Lindus Health is a clinical research organization that specializes in managing end-to-end clinical trials for healthcare and biotechnology companies. The company offers services such as ethics and IRB submissions, trial monitoring, data management, biostatistics, regulatory affairs, and payor relations. Lindus Health employs an in-house team of clinicians and researchers to accelerate the clinical trial process using its proprietary software platform, Curebase OS, which automates workflows and reduces manual inefficiencies. The company also leverages real-world patient data for precise participant recruitment and smarter trial design, aiming to make clinical trials faster and more cost-effective while improving patient treatment outcomes.

Operator of a cell-based biotechnology platform designed to produce messenger ribonucleic acid(mRNA) therapeutics and vaccines. The company's platform uses cell engineering, computational biology, and precision fermentation to optimize the production of vaccinia capping enzymes, enabling medical professionals to provide optimal medicines to their patients.

Seqera is a developer of workflow orchestration software that simplifies complex data analysis pipelines for life sciences research. The company's platform consolidates fragmented data and computing resources, allowing scientists to efficiently assemble and deploy scalable data analysis pipelines across multi-cloud environments. This capability enables researchers to tackle complex problems in genomics and global health, enhancing productivity and accelerating the pace of discovery. Trusted by over 150 leading organizations in the life sciences sector, Seqera's software empowers scientists to work with larger datasets and complete their analyses more quickly and confidently. Through its innovative approach, Seqera drives advancements in research and fosters collaboration within the scientific community.

Hedera Dx is a healthcare company established on July 1, 2021, in Epalinges, Vaud, specializing in liquid biopsy solutions aimed at enhancing cancer detection and treatment. The company's innovative system enables hospital laboratories to perform clinically useful liquid biopsies independently, simplifying the process of tumor profiling. By addressing challenges related to compliance, privacy, and validation, Hedera Dx offers a streamlined experience for clinicians, facilitating early detection, therapy selection, and monitoring of cancer recurrence. This technology not only aids in reducing cancer risks but also presents opportunities to lower mortality rates and healthcare costs.

Kernal Biologics, Inc. is a biotechnology company focused on designing and developing mRNA immunotherapies aimed at treating diseases such as COVID-19 and various cancers. Founded in 2016 and headquartered in Cambridge, Massachusetts, the company leverages its mRNA platform to enable researchers and organizations to create vaccines and therapeutics. Kernal’s innovative approach allows specific cells to produce their own therapeutic agents. With a team that has strong connections to prestigious institutions like MIT and Harvard, as well as experience in the pharmaceutical industry, Kernal Biologics has garnered recognition for its work, winning multiple awards from notable organizations, including Amgen and NASA.

Aware is a company that specializes in developing a mobile application aimed at evaluating health data and researching chronic diseases. The application helps users monitor and improve their health by providing insights into their bodily conditions. Aware offers blood tests through a subscription model, allowing customers to gain a deeper understanding of their health. By leveraging data, the company empowers clients to take control of their well-being and make informed decisions about their health.

Junction (formerly Vital) allows developers to access health data from wearable devices and at-home test kits. The company was founded in 2021 by Maitham Dib and is headquartered in San Francisco, California, United States.

Kano Therapeutics is a biotechnology company dedicated to advancing genome-editing therapies through innovative biomaterials. The company specializes in the correction of gene-length DNA using circular single-stranded DNA biomaterials, providing a comprehensive platform that integrates manufacturing, application, and computational tools for genetic payload development. By leveraging DNA nanotechnology and synthetic biology, Kano Therapeutics designs and engineers novel gene vectors that effectively carry genetic information. This enables researchers and pharmaceutical companies to enhance gene delivery methods and develop vaccine constructs, ultimately supporting the progression of genetic cures in a safe and efficient manner.

Vira Health is a digital health company dedicated to enhancing long-term health outcomes for women by focusing on female-specific conditions. It specializes in developing digital therapeutics that provide evidence-based interventions for managing menopause symptoms, including insomnia, anxiety, depression, hot flushes, weight gain, and incontinence. Vira's approach emphasizes personalized care and tailored treatments, which not only assist women in coping with the complexities of menopause but also aim to delay the onset of chronic conditions such as osteoporosis, cardiovascular disease, and dementia. Through improved collection and utilization of female health data, Vira Health seeks to address the unique healthcare needs of women and promote better health management throughout their lives.

Nostos Genomics is a biotechnology company that focuses on providing clear and timely diagnoses for individuals with genetic diseases. The company collaborates with genetic testing laboratories by offering a platform that integrates machine learning with synthetic biology. Its proprietary technology utilizes a machine-learning algorithm to automatically identify likely pathogenic variants, which enhances the diagnostic yield for labs. This innovation not only accelerates the interpretation of complex genetic cases but also supports laboratories in optimizing their operations and improving patient outcomes. Through its efforts, Nostos Genomics aims to streamline the diagnostic process for genetic conditions, making it more accessible to those in need.

Kenbi is a nurse-centric outpatient care company focused on enhancing the delivery of healthcare services. It provides outpatient care management aimed at supporting nurses and addressing gaps in the healthcare system. By leveraging technology, collegial organizational structures, and human-centric design, Kenbi organizes local care teams to deliver a range of outpatient and at-home services. These services include medical care covered by insurance, as well as household assistance, guidance, and companionship for patients. The company's approach is designed to reduce the time healthcare practitioners spend on bureaucratic tasks, allowing them to focus more on patient care and improving the overall experience for patients and their families.

Aware is a company that specializes in developing a mobile application aimed at evaluating health data and researching chronic diseases. The application helps users monitor and improve their health by providing insights into their bodily conditions. Aware offers blood tests through a subscription model, allowing customers to gain a deeper understanding of their health. By leveraging data, the company empowers clients to take control of their well-being and make informed decisions about their health.

Lindus Health is a clinical research organization that specializes in managing end-to-end clinical trials for healthcare and biotechnology companies. The company offers services such as ethics and IRB submissions, trial monitoring, data management, biostatistics, regulatory affairs, and payor relations. Lindus Health employs an in-house team of clinicians and researchers to accelerate the clinical trial process using its proprietary software platform, Curebase OS, which automates workflows and reduces manual inefficiencies. The company also leverages real-world patient data for precise participant recruitment and smarter trial design, aiming to make clinical trials faster and more cost-effective while improving patient treatment outcomes.

Seqera is a developer of workflow orchestration software that simplifies complex data analysis pipelines for life sciences research. The company's platform consolidates fragmented data and computing resources, allowing scientists to efficiently assemble and deploy scalable data analysis pipelines across multi-cloud environments. This capability enables researchers to tackle complex problems in genomics and global health, enhancing productivity and accelerating the pace of discovery. Trusted by over 150 leading organizations in the life sciences sector, Seqera's software empowers scientists to work with larger datasets and complete their analyses more quickly and confidently. Through its innovative approach, Seqera drives advancements in research and fosters collaboration within the scientific community.

Vira Health is a digital health company dedicated to enhancing long-term health outcomes for women by focusing on female-specific conditions. It specializes in developing digital therapeutics that provide evidence-based interventions for managing menopause symptoms, including insomnia, anxiety, depression, hot flushes, weight gain, and incontinence. Vira's approach emphasizes personalized care and tailored treatments, which not only assist women in coping with the complexities of menopause but also aim to delay the onset of chronic conditions such as osteoporosis, cardiovascular disease, and dementia. Through improved collection and utilization of female health data, Vira Health seeks to address the unique healthcare needs of women and promote better health management throughout their lives.

NuvoAir AB, established in 2015 and headquartered in Stockholm, Sweden, specializes in remote patient monitoring for chronic heart and lung conditions. The company's core product is Air Next, a home spirometer that tracks lung function. NuvoAir's innovative platform combines this advanced monitoring technology with personalized care from a multidisciplinary team, including pulmonologists and cardiologists. By collaborating with health plans and risk-bearing entities, NuvoAir offers a value-based care model that aims to reduce healthcare costs and improve patient outcomes.

Anima is a next-generation clinical operating system designed to enhance the efficiency of care teams in delivering optimal care plans to patients swiftly. The platform facilitates online consultations and offers a range of features, including comprehensive patient history management, one-click coding for record-keeping, and automated patient communications. It also incorporates limited assignment capabilities and patient access, along with integrated email and SMS messaging. Anima's advanced assignment and triage functionalities streamline workflows, while its full integration with electronic health records (EHR) ensures that notes are automatically generated, coded, and saved in the patient's record.

Anima is a next-generation clinical operating system designed to enhance the efficiency of care teams in delivering optimal care plans to patients swiftly. The platform facilitates online consultations and offers a range of features, including comprehensive patient history management, one-click coding for record-keeping, and automated patient communications. It also incorporates limited assignment capabilities and patient access, along with integrated email and SMS messaging. Anima's advanced assignment and triage functionalities streamline workflows, while its full integration with electronic health records (EHR) ensures that notes are automatically generated, coded, and saved in the patient's record.

Kenbi is a nurse-centric outpatient care company focused on enhancing the delivery of healthcare services. It provides outpatient care management aimed at supporting nurses and addressing gaps in the healthcare system. By leveraging technology, collegial organizational structures, and human-centric design, Kenbi organizes local care teams to deliver a range of outpatient and at-home services. These services include medical care covered by insurance, as well as household assistance, guidance, and companionship for patients. The company's approach is designed to reduce the time healthcare practitioners spend on bureaucratic tasks, allowing them to focus more on patient care and improving the overall experience for patients and their families.

Awell Health is a healthcare technology company focused on improving patient outcomes through the creation and implementation of care pathways. The company offers a cloud-based platform that integrates with existing clinical workflows, allowing healthcare organizations to automate routine clinical tasks and synchronize data across various systems. By facilitating seamless coordination between care teams and patients, Awell Health empowers physicians and care teams to make informed decisions at each stage of the patient care journey. Recognizing that the healthcare sector often relies on disjointed and outdated processes, Awell Health aims to reorganize these workflows, moving beyond mere data collection to enhance the overall efficiency and effectiveness of care delivery.

Allcyte is a biotech start-up specializing in functional drug testing using primary human materials. The company has developed a high-content imaging platform known as Pharmacoscopy, which incorporates AI-supported image analysis to assess drug effects at the single-cell level. This technology closely simulates in vivo conditions, allowing for a realistic preview of drug efficacy in actual patients. Allcyte's mission is to advance personalized medicine for cancer treatment by providing physicians and pharmaceutical companies with critical insights to prioritize the most suitable drugs for specific indications. By minimizing sample manipulation and employing sophisticated statistical and machine learning techniques, Allcyte aims to enhance biomedical decision-making and optimize cancer treatment outcomes.

Nostos Genomics is a biotechnology company that focuses on providing clear and timely diagnoses for individuals with genetic diseases. The company collaborates with genetic testing laboratories by offering a platform that integrates machine learning with synthetic biology. Its proprietary technology utilizes a machine-learning algorithm to automatically identify likely pathogenic variants, which enhances the diagnostic yield for labs. This innovation not only accelerates the interpretation of complex genetic cases but also supports laboratories in optimizing their operations and improving patient outcomes. Through its efforts, Nostos Genomics aims to streamline the diagnostic process for genetic conditions, making it more accessible to those in need.

Seqera is a developer of workflow orchestration software that simplifies complex data analysis pipelines for life sciences research. The company's platform consolidates fragmented data and computing resources, allowing scientists to efficiently assemble and deploy scalable data analysis pipelines across multi-cloud environments. This capability enables researchers to tackle complex problems in genomics and global health, enhancing productivity and accelerating the pace of discovery. Trusted by over 150 leading organizations in the life sciences sector, Seqera's software empowers scientists to work with larger datasets and complete their analyses more quickly and confidently. Through its innovative approach, Seqera drives advancements in research and fosters collaboration within the scientific community.

Hedera Dx is a healthcare company established on July 1, 2021, in Epalinges, Vaud, specializing in liquid biopsy solutions aimed at enhancing cancer detection and treatment. The company's innovative system enables hospital laboratories to perform clinically useful liquid biopsies independently, simplifying the process of tumor profiling. By addressing challenges related to compliance, privacy, and validation, Hedera Dx offers a streamlined experience for clinicians, facilitating early detection, therapy selection, and monitoring of cancer recurrence. This technology not only aids in reducing cancer risks but also presents opportunities to lower mortality rates and healthcare costs.

Inductive Bio is a company focused on enhancing the drug development process through its advanced machine learning platform. The company specializes in creating datasets and machine learning models that address the critical factors of Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) in small molecules. By providing the necessary information and tools, Inductive Bio enables scientists to optimize initial compounds into viable leads and development candidates more efficiently. This approach accelerates the compound optimization process, ultimately facilitating the development of new therapeutics with improved properties.